Mesenchymal Stem Cell-Based Therapy as an Alternative to the Treatment of Acute Respiratory Distress Syndrome: Current Evidence and Future Perspectives

Mesenchymal Stem Cell-Based Therapy as an Alternative to the Treatment of Acute Respiratory Distress Syndrome: Current Evidence and Future Perspectives

Acute respiratory distress syndrome (ARDS) represents a current challenge for medicine due to its incidence, morbidity and mortality and, also, the absence of an optimal treatment. The COVID-19 outbreak only increased the urgent demand for an affordable, safe and effective treatment for this process...

Full description

Bibliographic Details
Main Authors: Silvia Fernández-Francos, Noemi Eiro, Natalia González-Galiano, Francisco J. Vizoso
Format: Article
Language:English
Published: MDPI AG 2021-07-01
Series:International Journal of Molecular Sciences
Subjects:
COVID-19
pneumonia
acute respiratory distress syndrome
acute lung injury
mesenchymal stem cells
exosomes
Online Access:https://www.mdpi.com/1422-0067/22/15/7850

Similar Items

Similar Items